Welcome, Guest. Please login or register.
June 04, 2023, 07:24:39 pm

Login with username, password and session length

  • Total Posts: 55098
  • Total Topics: 4847
  • Online Today: 50
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 27
Total: 27


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Youth Hep C Testing, Treatment Rates Are Inadequate  (Read 2924 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Youth Hep C Testing, Treatment Rates Are Inadequate
« on: March 30, 2020, 12:57:59 pm »
Even as the opioid epidemic causes a surge of new cases of hepatitis C virus (HCV) among young people, testing for the virus in this population remains suboptimal, and actual treatment is rare.

According to the Centers for Disease Control and Prevention (CDC), the proportion of the U.S. hep C population that was between 15 and 24 years old increased from 3.8% in 2009 to 9.1% in 2013 to 2016. Today, the majority of new cases are among people younger than 30 years old who inject drugs. Indeed, injection drug use—specifically, the sharing of drug injection equipment—is the major risk factor for transmission among young adults.



© 2023 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.